171 related articles for article (PubMed ID: 15952716)
41. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
42. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
43. Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured glioblastoma cells.
Gagliano N; Moscheni C; Torri C; Donetti E; Magnani I; Costa F; Nowicky W; Gioia M
Anticancer Drugs; 2007 Jul; 18(6):669-76. PubMed ID: 17762395
[TBL] [Abstract][Full Text] [Related]
44. Proteome- and microarray-based expression analysis of lymphoma cell lines identifies a p53-centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma.
Weinkauf M; Christopeit M; Hiddemann W; Dreyling M
Electrophoresis; 2007 Dec; 28(23):4416-26. PubMed ID: 17990259
[TBL] [Abstract][Full Text] [Related]
45. Fascin expression in 90 patients with glioblastoma multiforme.
Roma AA; Prayson RA
Ann Diagn Pathol; 2005 Dec; 9(6):307-11. PubMed ID: 16308158
[TBL] [Abstract][Full Text] [Related]
46. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
[TBL] [Abstract][Full Text] [Related]
47. Q-modification of tRNAs in human brain tumors.
Aytaç U; Gündüz U
Cancer Biochem Biophys; 1994 Sep; 14(2):93-8. PubMed ID: 7889496
[TBL] [Abstract][Full Text] [Related]
48. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
49. A reference map of human nasopharyngeal squamous carcinoma proteome.
Li F; Xiao Z; Zhang P; Li J; Li M; Feng X; Guan Y; Chen Z
Int J Oncol; 2007 May; 30(5):1077-88. PubMed ID: 17390009
[TBL] [Abstract][Full Text] [Related]
50. Upregulation of frizzled 9 in astrocytomas.
Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
[TBL] [Abstract][Full Text] [Related]
51. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects.
Eckerich C; Zapf S; Ulbricht U; Müller S; Fillbrandt R; Westphal M; Lamszus K
Glia; 2006 Jan; 53(1):1-12. PubMed ID: 16078236
[TBL] [Abstract][Full Text] [Related]
52. Proteomic profiling of acute cardiac allograft rejection.
Kienzl K; Sarg B; Golderer G; Obrist P; Werner ER; Werner-Felmayer G; Lindner H; Maglione M; Schneeberger S; Margreiter R; Brandacher G
Transplantation; 2009 Aug; 88(4):553-60. PubMed ID: 19696639
[TBL] [Abstract][Full Text] [Related]
53. Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma.
Qi YJ; He QY; Ma YF; Du YW; Liu GC; Li YJ; Tsao GS; Ngai SM; Chiu JF
J Cell Biochem; 2008 Aug; 104(5):1625-35. PubMed ID: 18320592
[TBL] [Abstract][Full Text] [Related]
54. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
[TBL] [Abstract][Full Text] [Related]
55. Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.
Gunal A; Onguru O; Safali M; Beyzadeoglu M
Neuropathology; 2008 Aug; 28(4):382-6. PubMed ID: 18298442
[TBL] [Abstract][Full Text] [Related]
56. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma.
Neurath KM; Keough MP; Mikkelsen T; Claffey KP
Glia; 2006 May; 53(7):733-43. PubMed ID: 16518831
[TBL] [Abstract][Full Text] [Related]
57. RAF expression in human astrocytic tumors.
Hagemann C; Gloger J; Anacker J; Said HM; Gerngras S; Kühnel S; Meyer C; Rapp UR; Kämmerer U; Vordermark D; Flentje M; Roosen K; Vince GH
Int J Mol Med; 2009 Jan; 23(1):17-31. PubMed ID: 19082503
[TBL] [Abstract][Full Text] [Related]
58. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
[TBL] [Abstract][Full Text] [Related]
59. Human-specific c-neu proto-oncogene protein overexpression in human malignant astrocytomas before and after xenografting.
Bernstein JJ; Anagnostopoulos AV; Hattwick EA; Laws ER
J Neurosurg; 1993 Feb; 78(2):240-51. PubMed ID: 8093625
[TBL] [Abstract][Full Text] [Related]
60. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma.
Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ
Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
